Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 676 publications
Four-channel carbon dot fluorescent sensor array with a pattern recognition approach for the discrimination and quantification of rifamycin antibiotics.
Journal: Mikrochimica acta
Published: August 15, 2025
ThiPhiSA: new pathways to TB prevention from community screening - a household-randomised controlled trial in KwaZulu-Natal, South Africa.
Journal: BMJ open
Published: August 13, 2025
Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatment.
Journal: Frontiers in pharmacology
Published: July 16, 2025
A High-Performance Liquid Chromatography-Mass Spectrometry method for simultaneous determination of dolutegravir, nevirapine, efavirenz, rifampicin and rifapentine concentrations in human plasma.
Journal: medRxiv : the preprint server for health sciences
Published: June 30, 2025
Development and hepatotoxicity of rifamycin derivatives.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 25, 2025
Fabrication of flexibility-rigidity alternately assembled solid-state luminescence covalent organic frameworks: application to rifampicin antibiotics detection and latent fingerprint recognition.
Journal: Mikrochimica acta
Published: June 12, 2025
The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution.
Journal: American journal of respiratory and critical care medicine
Published: June 12, 2025
Reply to Wilson et al.: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution.
Journal: American journal of respiratory and critical care medicine
Published: June 12, 2025
Efficacy and safety of a novel short course rifapentine and isoniazid regimen for the preventive treatment of tuberculosis in Chinese silicosis patients: a pilot study (SCRIPT-TB).
Journal: Emerging microbes & infections
Published: May 06, 2025
Safety, feasibility and rifapentine plasma concentration in Chinese children with 1 month of daily rifapentine plus isoniazid for tuberculosis infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 30, 2025
Mannosamine-Modified Poly(lactic-co-glycolic acid)-Polyethylene Glycol Nanoparticles for the Targeted Delivery of Rifapentine and Isoniazid in Tuberculosis Therapy.
Journal: Bioconjugate chemistry
Published: April 22, 2025
Last Updated: 10/31/2025